Thomas A. Mccourt
Chief Executive Officer at Ironwood Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: Ironwood Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ironwood Pharmaceuticals Inc. June 16, 202697.7%
-
Ironwood Pharmaceuticals Inc. June 10, 202597.7%
-
Ironwood Pharmaceuticals Inc. June 21, 202498.6%
-
Ironwood Pharmaceuticals Inc. June 20, 202398.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Ironwood Pharmaceuticals Inc. | Grant or award | +409,836 | — | — |
| Feb 24, 2026 | Ironwood Pharmaceuticals Inc. | Open-market sale | −103,526 | $3.66 | $378,905 |
| Feb 23, 2026 | Ironwood Pharmaceuticals Inc. | Open-market sale | −94,757 | $3.81 | $361,024 |
| May 20, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +540,000 | — | — |
| May 16, 2025 | Ironwood Pharmaceuticals Inc. | Open-market sale | −13,353 | $0.58 | $7,745 |
| Feb 10, 2025 | Ironwood Pharmaceuticals Inc. | Open-market sale | −139,064 | $1.76 | $244,753 |
| Jan 17, 2025 | Ironwood Pharmaceuticals Inc. | Grant or award | +147,354 | — | — |
| May 20, 2024 | Ironwood Pharmaceuticals Inc. | Open-market sale | −67,618 | $6.45 | $436,136 |
| Mar 8, 2024 | Ironwood Pharmaceuticals Inc. | Option exercise | +120,298 | — | — |
| Mar 5, 2024 | Ironwood Pharmaceuticals Inc. | Grant or award | +264,876 | — | — |
| Feb 12, 2024 | Ironwood Pharmaceuticals Inc. | Open-market sale | −177,164 | $15.24 | $2,699,979 |
| Jan 17, 2024 | Ironwood Pharmaceuticals Inc. | Grant or award | +249,617 | — | — |
| May 30, 2023 | Ironwood Pharmaceuticals Inc. | Open-market sale | −26,632 | $10.70 | $284,962 |
| May 22, 2023 | Ironwood Pharmaceuticals Inc. | Open-market sale | −36,000 | $10.12 | $364,320 |
| May 8, 2023 | Ironwood Pharmaceuticals Inc. | Open-market sale | −21,148 | $10.62 | $224,592 |
Questions about Thomas A. Mccourt
What boards is Thomas A. Mccourt on?
Thomas A. Mccourt sits on the boards of Ironwood Pharmaceuticals Inc. and Pliant Therapeutics Inc.
What company is Thomas A. Mccourt the CEO of?
Thomas A. Mccourt is Chief Executive Officer of Ironwood Pharmaceuticals Inc.
How long has Thomas A. Mccourt served on boards?
Our records show at least 8 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.